Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation?-Reference-Cited by-同舟云学术

Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation?

Published:2019-05-31 Issue:9 Volume:26 Page:2959-2968
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Sahara Kota,Tsilimigras Diamantis I.,Merath Katiuscha,Bagante Fabio,Guglielmi Alfredo,Aldrighetti Luca,Weiss Matthew,Bauer Todd W.,Alexandrescu Sorin,Poultsides George A.,Maithel Shishir K.,Marques Hugo P.,Martel Guillaume,Pulitano Carlo,Shen Feng,Soubrane Olivier,Koerkamp B. Groot,Matsuyama Ryusei,Endo Itaru,Pawlik Timothy M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-019-07483-9.pdf

Reference34 articles.

1. Chang KY, Chang JY, Yen Y. Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. J Natl Compr Cancer Netw. 2009;7(4):423–7.

2. Amini N, Ejaz A, Spolverato G, Kim Y, Herman JM, Pawlik TM. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. J Surg Oncol. 2014;110(2):163–70.

3. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979–94. The Lancet. 1997;350(9085):1142–3.

4. Shirabe K, Shimada M, Harimoto N, et al. Intrahepatic cholangiocarcinoma: Its mode of spreading and therapeutic modalities. Surgery. 2002;131(1 Suppl 1):S159–S164.

5. Shen WF, Zhong W, Xu F, et al. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol. 2009;15(47):5976–82.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review;Surgery Today;2024-04-02

2. The State of Systematic Therapies in Clinic for Hepatobiliary Cancers;Journal of Hepatocellular Carcinoma;2024-03

3. Impact of Tumor Subclassifications for Identifying an Appropriate Surgical Strategy in Patients with Intrahepatic Cholangiocarcinoma;Annals of Surgical Oncology;2024-01-05

4. Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma;Journal of Gastrointestinal Surgery;2024-01

5. Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis;BMC Surgery;2023-11-30